JP2024514597A5 - - Google Patents
Info
- Publication number
- JP2024514597A5 JP2024514597A5 JP2023562695A JP2023562695A JP2024514597A5 JP 2024514597 A5 JP2024514597 A5 JP 2024514597A5 JP 2023562695 A JP2023562695 A JP 2023562695A JP 2023562695 A JP2023562695 A JP 2023562695A JP 2024514597 A5 JP2024514597 A5 JP 2024514597A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- formula
- pharmaceutically acceptable
- independently selected
- acceptable salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020210052441A KR20220145981A (ko) | 2021-04-22 | 2021-04-22 | 트리아졸론, 테트라졸론, 및 이미다졸론, 또는 그의 염, 및 그를 포함하는 제약 조성물 |
| KR10-2021-0052441 | 2021-04-22 | ||
| PCT/IB2022/053747 WO2022224195A1 (en) | 2021-04-22 | 2022-04-21 | Triazolones, tetrazolones, and imidazolones, or their salts, and pharmaceutical compositions comprising the same |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024514597A JP2024514597A (ja) | 2024-04-02 |
| JP2024514597A5 true JP2024514597A5 (https=) | 2025-04-02 |
Family
ID=83722734
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023562695A Pending JP2024514597A (ja) | 2021-04-22 | 2022-04-21 | トリアゾロン、テトラゾロン、及びイミダゾロン、又はその塩、並びにそれを含む医薬組成物 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US12110279B2 (https=) |
| EP (1) | EP4326715A4 (https=) |
| JP (1) | JP2024514597A (https=) |
| KR (2) | KR20220145981A (https=) |
| CN (1) | CN117203205A (https=) |
| AU (1) | AU2022262845A1 (https=) |
| CA (1) | CA3216511A1 (https=) |
| TW (1) | TW202309012A (https=) |
| WO (1) | WO2022224195A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW202039486A (zh) | 2018-12-14 | 2020-11-01 | 南韓商柳韓洋行股份有限公司 | 三唑并吡啶-3-酮化物或其鹽及包含彼之醫藥組合物 |
| TWI835945B (zh) * | 2018-12-14 | 2024-03-21 | 南韓商柳韓洋行股份有限公司 | 3,3-二氟烯丙胺化物或其鹽及包含彼的醫藥組合物 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH09110863A (ja) * | 1995-08-10 | 1997-04-28 | Nissan Chem Ind Ltd | 新規テトラゾリノン類 |
| WO2018027892A1 (en) * | 2016-08-12 | 2018-02-15 | Eli Lilly And Company | Amino pyrimidine ssao inhibitors |
| KR20190110736A (ko) * | 2018-03-21 | 2019-10-01 | 주식회사유한양행 | 신규의 트라이아졸론 유도체 또는 이의 염 및 이를 포함하는 약학 조성물 |
| KR20190110740A (ko) * | 2018-03-21 | 2019-10-01 | 주식회사유한양행 | 신규의 아릴 또는 헤테로아릴 트라이아졸론 유도체 또는 이의 염 및 이를 포함하는 약학 조성물 |
| TW202039486A (zh) | 2018-12-14 | 2020-11-01 | 南韓商柳韓洋行股份有限公司 | 三唑并吡啶-3-酮化物或其鹽及包含彼之醫藥組合物 |
| TWI835945B (zh) | 2018-12-14 | 2024-03-21 | 南韓商柳韓洋行股份有限公司 | 3,3-二氟烯丙胺化物或其鹽及包含彼的醫藥組合物 |
-
2021
- 2021-04-22 KR KR1020210052441A patent/KR20220145981A/ko active Pending
-
2022
- 2022-04-21 CA CA3216511A patent/CA3216511A1/en active Pending
- 2022-04-21 TW TW111115157A patent/TW202309012A/zh unknown
- 2022-04-21 WO PCT/IB2022/053747 patent/WO2022224195A1/en not_active Ceased
- 2022-04-21 US US17/726,323 patent/US12110279B2/en active Active
- 2022-04-21 KR KR1020237038359A patent/KR20230173675A/ko active Pending
- 2022-04-21 JP JP2023562695A patent/JP2024514597A/ja active Pending
- 2022-04-21 AU AU2022262845A patent/AU2022262845A1/en active Pending
- 2022-04-21 CN CN202280028923.0A patent/CN117203205A/zh active Pending
- 2022-04-21 EP EP22791234.2A patent/EP4326715A4/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5008258B2 (ja) | 含硫黄ホスホリピド誘導体 | |
| JP7050751B2 (ja) | Ｎｌｒｐ活性に関連する状態を処置するための化合物および組成物 | |
| JP2024514597A5 (https=) | ||
| JP2020528889A5 (https=) | ||
| JP2022507065A5 (https=) | ||
| JP2010540508A5 (https=) | ||
| JP6770511B2 (ja) | 心肺障害の処置のためのスフィンゴシン−１−リン酸受容体モジュレーター | |
| JP2012522759A5 (https=) | ||
| JP2024513227A5 (https=) | ||
| CN105669751A (zh) | 非环核苷酸磷酰胺类化合物及其盐的制备以及在抗病毒方面的应用 | |
| JP2023510746A5 (https=) | ||
| JP5575651B2 (ja) | 新規のｄｈａ誘導体およびその医薬品としての用途 | |
| IL298169A (en) | enpp1 modulators and their uses | |
| DE69434198T2 (de) | Verfahren zur senkung des serumcholesterinspiegels mit 2,6-dialkyl-4 silyl-phenol derivaten | |
| JP2011502113A5 (https=) | ||
| WO2024140845A1 (zh) | 一种多臂聚乙二醇-药物偶联物 | |
| WO2011017907A1 (zh) | 氮杂环丁酮类化合物及医药应用 | |
| TW495509B (en) | Novel pyrimidine derivative | |
| CN110198929A (zh) | 用于治疗真菌感染的组合物和方法 | |
| JP2001510188A (ja) | ピラジン誘導体、それらの製造及びそれらを含有する薬剤 | |
| JP2022554330A5 (https=) | ||
| JPH02229168A (ja) | ピラゾロン誘導体 | |
| JP2022521474A5 (https=) | ||
| JP6854497B2 (ja) | インドールアミン−２，３−ジオキシゲナーゼ阻害剤としてのスルホニルアミディーン及びその製造方法と用途 | |
| CN120435467A (zh) | 补体因子b抑制剂及其药物组合物和应用 |